Header Logo

Connection

Kabirullah Lutfy to Mice

Back to Details
This is a "connection" page, showing publications Kabirullah Lutfy has written about Mice.
Kabirullah Lutfy
Connection Strength
3.200
Mice
  1. Chronic Exposure to E-Cigarettes Elevates CYP2A5 Activity, Protein Expression, and Cotinine-Induced Production of Reactive Oxygen Species in Mice. Drug Metab Dispos. 2024 Feb 14; 52(3):171-179.
    View in: PubMed
    Score: 0.190
  2. Small molecule NOP agonists reverse locomotor sensitization induced by cocaine in male C57BL/6 mice. Prog Neuropsychopharmacol Biol Psychiatry. 2024 Apr 20; 131:110941.
    View in: PubMed
    Score: 0.189
  3. Identification of 5-Hydroxycotinine in the Plasma of Nicotine-Treated Mice: Implications for Cotinine Metabolism and Disposition in Vivo. Drug Metab Dispos. 2022 Dec; 50(12):1454-1463.
    View in: PubMed
    Score: 0.173
  4. The role of pituitary adenylyl cyclase activating polypeptide in affective signs of nicotine withdrawal. J Neurosci Res. 2020 08; 98(8):1549-1560.
    View in: PubMed
    Score: 0.147
  5. The role of endogenous pituitary adenylyl cyclase activating polypeptide (PACAP) in nicotine self-administration, reward and aversion. Pharmacol Biochem Behav. 2019 06; 181:46-52.
    View in: PubMed
    Score: 0.137
  6. A Novel and Selective Nociceptin Receptor (NOP) Agonist (1-(1-((cis)-4-isopropylcyclohexyl)piperidin-4-yl)-1H-indol-2-yl)methanol (AT-312) Decreases Acquisition of Ethanol-Induced Conditioned Place Preference in Mice. Alcohol Clin Exp Res. 2018 Feb; 42(2):461-471.
    View in: PubMed
    Score: 0.125
  7. Nicotine pretreatment reduced cocaine-induced CPP and its reinstatement in a sex- and dose-related manner in adult C57BL/6J mice. Pharmacol Biochem Behav. 2017 08; 159:84-89.
    View in: PubMed
    Score: 0.121
  8. The role of endogenous beta-endorphin and enkephalins in ethanol reward. Neuropharmacology. 2013 Oct; 73:290-300.
    View in: PubMed
    Score: 0.091
  9. The role of NOP receptors in psychomotor stimulation and locomotor sensitization induced by cocaine and amphetamine in mice. Eur J Pharmacol. 2013 May 05; 707(1-3):41-5.
    View in: PubMed
    Score: 0.089
  10. The rewarding action of acute cocaine is reduced in ß-endorphin deficient but not in µ opioid receptor knockout mice. Eur J Pharmacol. 2012 Jul 05; 686(1-3):50-4.
    View in: PubMed
    Score: 0.084
  11. The role of mu opioid receptors in psychomotor stimulation and conditioned place preference induced by morphine-6-glucuronide. Eur J Pharmacol. 2012 May 05; 682(1-3):86-91.
    View in: PubMed
    Score: 0.083
  12. Nicotine stimulates secretion of corticosterone via both CRH and AVP receptors. J Neurochem. 2012 Mar; 120(6):1108-16.
    View in: PubMed
    Score: 0.083
  13. The role of endogenous dynorphin in ethanol-induced state-dependent CPP. Behav Brain Res. 2012 Feb 01; 227(1):58-63.
    View in: PubMed
    Score: 0.081
  14. Stress-induced analgesia and endogenous opioid peptides: the importance of stress duration. Eur J Pharmacol. 2011 Jan 15; 650(2-3):563-7.
    View in: PubMed
    Score: 0.076
  15. Orphanin FQ/nociceptin not only blocks but also reverses behavioral adaptive changes induced by repeated cocaine in mice. Biol Psychiatry. 2010 Aug 01; 68(3):223-30.
    View in: PubMed
    Score: 0.073
  16. The role of endogenous PACAP in motor stimulation and conditioned place preference induced by morphine in mice. Psychopharmacology (Berl). 2009 Jun; 204(3):457-63.
    View in: PubMed
    Score: 0.067
  17. The role of the opioid receptor-like (ORL1) receptor in motor stimulatory and rewarding actions of buprenorphine and morphine. Neuroscience. 2008 Aug 26; 155(3):597-602.
    View in: PubMed
    Score: 0.064
  18. The role of beta-endorphin in the acute motor stimulatory and rewarding actions of cocaine in mice. Psychopharmacology (Berl). 2008 Apr; 197(3):443-8.
    View in: PubMed
    Score: 0.062
  19. The endogenous OFQ/N/ORL-1 receptor system regulates the rewarding effects of acute cocaine. Neuropharmacology. 2008 Mar; 54(3):564-8.
    View in: PubMed
    Score: 0.062
  20. The mu opioid receptor is involved in buprenorphine-induced locomotor stimulation and conditioned place preference. Neuropharmacology. 2007 May; 52(6):1336-41.
    View in: PubMed
    Score: 0.058
  21. Repeated stress alters the ability of nicotine to activate the hypothalamic-pituitary-adrenal axis. J Neurochem. 2006 Dec; 99(5):1321-7.
    View in: PubMed
    Score: 0.057
  22. Differential involvement of enkephalins in analgesic tolerance, locomotor sensitization, and conditioned place preference induced by morphine. Behav Neurosci. 2006 Feb; 120(1):10-5.
    View in: PubMed
    Score: 0.055
  23. E-Cigarette Smoke Exposure Elevates Renal MR Expression and Induces BP Elevation. Hypertension. 2025 Sep; 82(9):1492-1504.
    View in: PubMed
    Score: 0.052
  24. Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors. J Neurosci. 2003 Nov 12; 23(32):10331-7.
    View in: PubMed
    Score: 0.047
  25. Brain-derived neurotrophic factor overexpression in taste buds diminishes chemotherapy induced taste loss. Eur J Neurosci. 2022 10; 56(7):4967-4982.
    View in: PubMed
    Score: 0.043
  26. Decreased 11ß-Hydroxysteroid Dehydrogenase Type 2 Expression in the Kidney May Contribute to Nicotine/Smoking-Induced Blood Pressure Elevation in Mice. Hypertension. 2021 06; 77(6):1940-1952.
    View in: PubMed
    Score: 0.039
  27. Effects of ACEA-1328, a NMDA receptor/glycine site antagonist, on U50,488H-induced antinociception and tolerance. Eur J Pharmacol. 1999 Nov 12; 384(1):1-5.
    View in: PubMed
    Score: 0.035
  28. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine. Pharmacol Res. 1999 Nov; 40(5):435-42.
    View in: PubMed
    Score: 0.035
  29. A mouse model for chronic intermittent electronic cigarette exposure exhibits nicotine pharmacokinetics resembling human vapers. J Neurosci Methods. 2019 10 01; 326:108376.
    View in: PubMed
    Score: 0.035
  30. ACEA-1328, an NMDA receptor antagonist, increases the potency of morphine and U50,488H in the tail flick test in mice. Pharmacol Res. 1998 Dec; 38(6):453-60.
    View in: PubMed
    Score: 0.033
  31. Tolerance develops to the antinociceptive and motor impairing effects of ACEA-1416, a NMDA receptor antagonist, in the formalin and rotarod test in mice. Pharmacol Res. 1998 Apr; 37(4):295-302.
    View in: PubMed
    Score: 0.032
  32. Enhanced hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to diet-induced visceral adiposity. Int J Obes (Lond). 2018 12; 42(12):1999-2011.
    View in: PubMed
    Score: 0.031
  33. a7-Nicotinic Acetylcholine Receptor Agonist Ameliorates Nicotine Plus High-Fat Diet-Induced Hepatic Steatosis in Male Mice by Inhibiting Oxidative Stress and Stimulating AMPK Signaling. Endocrinology. 2018 02 01; 159(2):931-944.
    View in: PubMed
    Score: 0.031
  34. Antinociceptive effects of NMDA and non-NMDA receptor antagonists in the tail flick test in mice. Pain. 1997 Mar; 70(1):31-40.
    View in: PubMed
    Score: 0.029
  35. Attenuation of nociceptive responses by ACEA-1021, a competitive NMDA receptor/glycine site antagonist, in the mice. Brain Res. 1996 Dec 16; 743(1-2):17-23.
    View in: PubMed
    Score: 0.029
  36. Inhibition of morphine tolerance by NMDA receptor antagonists in the formalin test. Brain Res. 1996 Aug 26; 731(1-2):171-81.
    View in: PubMed
    Score: 0.028
  37. Differential sensitivity of mice bred for stress-induced analgesia to morphine and ACEA-1011 in the formalin test. Pharmacol Biochem Behav. 1996 Jun; 54(2):495-500.
    View in: PubMed
    Score: 0.028
  38. Increased glycogen synthase kinase-3ß and hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to glucocorticoid-induced mouse visceral adiposity. Int J Obes (Lond). 2016 08; 40(8):1233-41.
    View in: PubMed
    Score: 0.028
  39. Blockade of morphine tolerance by ACEA-1328, a novel NMDA receptor/glycine site antagonist. Eur J Pharmacol. 1995 Jan 24; 273(1-2):187-9.
    View in: PubMed
    Score: 0.025
  40. ACEA-1011, a novel NMDA receptor/glycine site antagonist, produces antinociception but not tolerance in the formalin test in mice. NIDA Res Monogr. 1995; 147:220-33.
    View in: PubMed
    Score: 0.025
  41. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature. 2015 Mar 12; 519(7542):242-6.
    View in: PubMed
    Score: 0.025
  42. Morphine analgesia and tolerance in mice selectively bred for divergent swim stress-induced analgesia. Eur J Pharmacol. 1994 Nov 24; 265(3):171-4.
    View in: PubMed
    Score: 0.025
  43. 11ß-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue. Am J Physiol Endocrinol Metab. 2015 Jan 01; 308(1):E84-95.
    View in: PubMed
    Score: 0.025
  44. Inhibition of clonic seizure-like excitatory effects induced by intrathecal morphine using two NMDA receptor antagonists: MK-801 and ACEA-1011. Eur J Pharmacol. 1994 Feb 11; 252(3):261-6.
    View in: PubMed
    Score: 0.024
  45. Transgenic overexpression of hexose-6-phosphate dehydrogenase in adipose tissue causes local glucocorticoid amplification and lipolysis in male mice. Am J Physiol Endocrinol Metab. 2014 Mar 01; 306(5):E543-51.
    View in: PubMed
    Score: 0.024
  46. Alterations in phosphorylated CREB expression in different brain regions following short- and long-term morphine exposure: relationship to food intake. J Obes. 2013; 2013:764742.
    View in: PubMed
    Score: 0.023
  47. Blockade of morphine-induced analgesia and tolerance in mice by MK-801. Brain Res. 1993 Jul 09; 616(1-2):83-8.
    View in: PubMed
    Score: 0.023
  48. Specific reduction of G6PT may contribute to downregulation of hepatic 11ß-HSD1 in diabetic mice. J Mol Endocrinol. 2013 Apr; 50(2):167-78.
    View in: PubMed
    Score: 0.022
  49. Effect of nicotine on body composition in mice. J Endocrinol. 2012 Mar; 212(3):317-26.
    View in: PubMed
    Score: 0.020
  50. Modification of morphine-induced analgesia and toxicity by pertussis toxin. Brain Res. 1991 Mar 29; 544(2):191-5.
    View in: PubMed
    Score: 0.020
  51. The role of opioid receptor density in morphine tolerance. J Pharmacol Exp Ther. 1991 Feb; 256(2):575-80.
    View in: PubMed
    Score: 0.019
  52. Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes. Diabetologia. 2011 Feb; 54(2):440-50.
    View in: PubMed
    Score: 0.019
  53. Simultaneous development of opioid tolerance and opioid antagonist-induced receptor upregulation. Brain Res. 1990 Oct 08; 529(1-2):143-8.
    View in: PubMed
    Score: 0.019
  54. The role of the NOP receptor in regulating food intake, meal pattern, and the excitability of proopiomelanocortin neurons. Neuropharmacology. 2010 Sep; 59(3):190-200.
    View in: PubMed
    Score: 0.018
  55. Gene expression profiling following short-term and long-term morphine exposure in mice uncovers genes involved in food intake. Neuroscience. 2010 May 05; 167(2):554-66.
    View in: PubMed
    Score: 0.018
  56. Chronic opioid antagonist treatment: assessment of receptor upregulation. Eur J Pharmacol. 1989 Nov 07; 170(3):193-200.
    View in: PubMed
    Score: 0.018
  57. Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice. J Mol Endocrinol. 2008 Aug; 41(2):53-64.
    View in: PubMed
    Score: 0.016
  58. Liver X receptor agonist T0901317 inhibition of glucocorticoid receptor expression in hepatocytes may contribute to the amelioration of diabetic syndrome in db/db mice. Endocrinology. 2006 Nov; 147(11):5061-8.
    View in: PubMed
    Score: 0.014
  59. Increased glucocorticoid receptor and 11{beta}-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice. Diabetes. 2005 Jan; 54(1):32-40.
    View in: PubMed
    Score: 0.013
  60. Effect of adrenal and sex hormones on opioid analgesia and opioid receptor regulation. Pharmacol Biochem Behav. 1992 Aug; 42(4):685-92.
    View in: PubMed
    Score: 0.005
  61. Potentiation of opioid analgesia by cocaine: the role of spinal and supraspinal receptors. Life Sci. 1992; 50(8):591-7.
    View in: PubMed
    Score: 0.005
  62. Dissociation of opioid receptor upregulation and functional supersensitivity. Pharmacol Biochem Behav. 1991 Apr; 38(4):853-9.
    View in: PubMed
    Score: 0.005
  63. Species differences in mu- and delta-opioid receptors. Eur J Pharmacol. 1991 Jan 25; 193(1):105-8.
    View in: PubMed
    Score: 0.005
  64. Tolerance develops to spinal morphine analgesia but not morphine-induced convulsions. Eur J Pharmacol. 1990 Jan 25; 176(1):63-7.
    View in: PubMed
    Score: 0.004
  65. In vitro d-amphetamine and cocaine increase opioid binding in mouse brain homogenate. NIDA Res Monogr. 1990; 105:522-3.
    View in: PubMed
    Score: 0.004
  66. Differentiation of spinal and supraspinal opioid receptors by morphine tolerance. Life Sci. 1990; 46(5):343-50.
    View in: PubMed
    Score: 0.004
  67. Chronic opioid antagonist treatment increases mu and delta receptor mediated spinal opioid analgesia. Brain Res. 1989 Apr 17; 485(1):176-8.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.